ByHeart providing customers with baby formula despite nationwide shortage
ByHeart CEO Ron Belldegrun discussed the baby formula shortage and being a part of the solution with FOX Business’ Lydia Hu.
While the U.S. is likely months away from seeing more baby formula back on the shelves, one company is looking to help fill the gap.
New York-based ByHeart debuted its baby formula on March 23 amid the perfect storm following a pandemic, an ingredient shortage driven by the war in Ukraine and a recall from a market share leader in the country, Abbott Nutrition. About 43% of baby formula is sold out across the country, according to data from Datasembly.
HOUSE APPROPRIATIONS COMMITTEE PREPS $28M EMERGENCY BILL TO ADDRESS BABY FORMULA SHORTAGE
Yet, the baby formula maker has avoided supply chain disruptions and kept supplies available because it relies on its own manufacturing and doesn’t outsource. Unlike other smaller and newer formula brands that are struggling to ramp up production, ByHeart has acquired its own manufacturing facility in Reading, Pennsylvania, after pursuing clinical trials and becoming the first formula maker to be registered with the FDA in fifteen years.